Gastrointestinal Tolerance of a Nutritional Supplement in Adult Patients With or at Risk of Malnu… (NCT04259437) | Clinical Trial Compass
CompletedNot Applicable
Gastrointestinal Tolerance of a Nutritional Supplement in Adult Patients With or at Risk of Malnutrition
United Kingdom46 participantsStarted 2020-03-10
Plain-language summary
The purpose of this study is to evaluate the GI tolerance, palatability and compliance to a high protein energy-dense oral nutrition supplement in adult patients with or at risk of malnutrition.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Subject has voluntarily signed and dated informed consent form approved by Independent Ethics Committee and provided applicable privacy authorization prior to any participation in the study.
* Subject is considered malnourished or at risk for malnutrition
* Subject has normal GI function
* Subject requires oral nutritional supplementation ands is willing to comply with the study protocol
Exclusion Criteria:
* Subject has severe dementia, eating disorder, history of significant neurological or psychiatric disorder affecting abilities to answer questions, alcoholism, substance abuse or other conditions that may interfere with study product consumption or compliance with study protocol procedures
* Subject has a history of diabetes
* Subject is currently taking antibiotics or has taken antibiotics within 1 week prior to enrollment
* Subject has undergone major GI surgery less than 3 months prior to enrollment
* Subject has active malignant disease or was treated within the last 6 months for cancer
* Subject has immunodeficiency disorder
* Subject has had a myocardial infarction within the last 3 months prior to enrollment
* Subject is known to be allergic to intolerant to an ingredient found in the study product
* Subject has an aversion to the flavor of product being tested
* Subject has an obstruction of the GI tract precluding ingestion or absorption of the study product, inflammatory bowel disease, gastric esophageal reflux disease, short bowel syndr…